SI1781662T1 - Zaviralci RNA-odvisne RNA-polimeraze hepatitisa C in sestavki in zdravljenja, v katerih se uporabljajo - Google Patents

Zaviralci RNA-odvisne RNA-polimeraze hepatitisa C in sestavki in zdravljenja, v katerih se uporabljajo

Info

Publication number: SI1781662T1
Authority: SI; Slovenia
Prior art keywords: hepatitis; treatments; inhibitors; compositions; same
Prior art date: 2004-08-18

Application number

SI200531314T

Other languages

English (en)

Inventor

Javier Gonzalez

Tanya Michelle Jewell

Hui Li

Angelica Linton

John Howard Tatlock

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-18

Filing date

2005-08-05

Publication date

2011-07-29

2005-08-05 Application filed by Pfizer filed Critical Pfizer

2011-07-29 Publication of SI1781662T1 publication Critical patent/SI1781662T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

SI200531314T 2004-08-18 2005-08-05 Zaviralci RNA-odvisne RNA-polimeraze hepatitisa C in sestavki in zdravljenja, v katerih se uporabljajo SI1781662T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US60261804P	2004-08-18	2004-08-18
EP05775853A EP1781662B1 (en)	2004-08-18	2005-08-05	Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
PCT/IB2005/002697 WO2006018725A1 (en)	2004-08-18	2005-08-05	Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same

Publications (1)

Publication Number	Publication Date
SI1781662T1 true SI1781662T1 (sl)	2011-07-29

Family

ID=35429645

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200531314T SI1781662T1 (sl)	2004-08-18	2005-08-05	Zaviralci RNA-odvisne RNA-polimeraze hepatitisa C in sestavki in zdravljenja, v katerih se uporabljajo

Country Status (43)

Country	Link
US (3)	US7151105B2 (sl)
EP (1)	EP1781662B1 (sl)
JP (1)	JP4372195B2 (sl)
KR (1)	KR100851178B1 (sl)
CN (2)	CN101538268B (sl)
AP (1)	AP2313A (sl)
AR (1)	AR050699A1 (sl)
AT (1)	ATE506364T1 (sl)
AU (1)	AU2005273619B2 (sl)
BR (1)	BRPI0514425A (sl)
CA (1)	CA2577525C (sl)
CR (2)	CR8935A (sl)
CY (1)	CY1111480T1 (sl)
DE (1)	DE602005027580D1 (sl)
DK (1)	DK1781662T3 (sl)
EA (1)	EA012605B1 (sl)
EC (1)	ECSP077264A (sl)
ES (1)	ES2361845T3 (sl)
GE (2)	GEP20115305B (sl)
GT (1)	GT200500221A (sl)
HK (1)	HK1109617A1 (sl)
HN (1)	HN2005000449A (sl)
HR (1)	HRP20110458T1 (sl)
IL (2)	IL180933A (sl)
MA (1)	MA28803B1 (sl)
MX (1)	MX2007001527A (sl)
MY (1)	MY146123A (sl)
NI (1)	NI200700043A (sl)
NL (1)	NL1029755C2 (sl)
NO (1)	NO20071274L (sl)
NZ (1)	NZ552874A (sl)
PE (1)	PE20060677A1 (sl)
PL (1)	PL1781662T3 (sl)
PT (1)	PT1781662E (sl)
RS (1)	RS51794B (sl)
SI (1)	SI1781662T1 (sl)
SV (1)	SV2007002202A (sl)
TN (1)	TNSN07066A1 (sl)
TW (1)	TWI376379B (sl)
UA (1)	UA88909C2 (sl)
UY (1)	UY29068A1 (sl)
WO (1)	WO2006018725A1 (sl)
ZA (1)	ZA200700779B (sl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006018725A1 (en) *	2004-08-18	2006-02-23	Pfizer Inc.	Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
EP1928878A1 (en) *	2005-08-24	2008-06-11	Pfizer Inc.	Methods for the preparation of hcv polymerase inhibitors
EP2494991A1 (en)	2007-05-04	2012-09-05	Vertex Pharmaceuticals Incorporated	Combination therapy for the treatment of HCV infection
EP2008996A1 (en) *	2007-06-27	2008-12-31	Syngeta Participations AG	Process for the production of pyrazoles
JP5820722B2 (ja)	2008-06-06	2015-11-24	スシネキスインク	シクロスポリン類似体及びｈｃｖ感染の治療におけるその使用
UA103195C2 (uk)	2008-08-11	2013-09-25	Глаксосмитклайн Ллк	Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
US8563717B2 (en)	2008-08-11	2013-10-22	Glaxosmithkline Llc	Adenine derivatives
EA201100114A1 (ru)	2008-08-11	2011-10-31	ГЛАКСОСМИТКЛАЙН ЭлЭлСи	Производные пурина для применения в лечении аллергических, воспалительных и инфекционных заболеваний
UY32940A (es)	2009-10-27	2011-05-31	Bayer Cropscience Ag	Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas
KR20120106942A (ko)	2009-10-30	2012-09-27	베링거 인겔하임 인터내셔날 게엠베하	Ｂｉ２０１３３５, 인터페론 알파 및 리바비린을 포함하는 ｈｃｖ 병용 치료요법을 위한 투여 용법
EP2325173A1 (de)	2009-11-19	2011-05-25	Bayer CropScience AG	Verfahren zum Herstellen von 5-Fluor-1-alkyl-3-fluoralkyl-1H-pyrazol-4-carbonsäurechloriden
CN102753173A (zh) *	2009-12-18	2012-10-24	贝林格尔.英格海姆国际有限公司	Hcv组合疗法
EA021048B1 (ru)	2010-02-10	2015-03-31	ГЛАКСОСМИТКЛАЙН ЭлЭлСи	Малеат 6-амино-2-{[(1s)-1-метилбутил]окси}-9-[5-(1-пиперидинил)пентил]-7,9-дигидро-8н-пурин-8-она
US8575340B2 (en)	2010-02-10	2013-11-05	Glaxosmithkline Llc	Purine derivatives and their pharmaceutical uses
JP5763179B2 (ja) *	2010-05-20	2015-08-12	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＧｍｂＨ	１−アルキル−３−ジフルオロメチル−５−ヒドロキシピラゾール類の製造方法
US8987307B2 (en)	2011-03-03	2015-03-24	Hoffmann-La Roche Inc.	3-amino-pyridines as GPBAR1 agonists
FR2972452B1 (fr)	2011-03-09	2013-03-15	Rhodia Operations	Procede de preparation du difluoroacetonitrile et de ses derives
CN104254523B (zh)	2012-05-14	2017-03-22	拜尔农作物科学股份公司	制备1‑烷基‑3‑氟烷基‑1h‑吡唑‑4‑羧酸氯的方法
WO2014081878A2 (en)	2012-11-21	2014-05-30	Stategics, Inc.	Substituted triazolo-pyrimidine compounds for modulating cell proliferation, differentiation and survival
DK2945933T3 (en)	2013-01-17	2017-01-23	Bayer Cropscience Ag	METHOD OF PREPARING 5-FLUORO-1-METHYL-3-DIFLUORMETHYL-1H-PYRAZOL-4-CARBALDEHYDE
ES2656012T3 (es)	2013-02-06	2018-02-22	Bayer Cropscience Aktiengesellschaft	Derivados de pirazol sustituidos con halógeno como pesticidas
AU2014375265B2 (en)	2014-01-03	2018-11-01	Elanco Animal Health Gmbh	Novel pyrazolyl-heteroarylamides as pesticides
DK3097081T3 (da)	2014-01-24	2018-01-29	Bayer Cropscience Ag	Fremgangsmåde til fremstilling af 1-alkyl-3-difluormethyl-5-fluor-1h-pyrazol-4-carbaldehyder og 1-alkyl-3-difluormethyl-5-fluor-1h-pyrazol-4-carboxylater
ES2655940T3 (es)	2014-02-20	2018-02-22	Glaxosmithkline Intellectual Property (No. 2) Limited	Derivados de pirrolo[3,2-d]pirimidina como inductores de interferón humano
PT3152199T (pt)	2014-06-03	2018-11-26	Idorsia Pharmaceuticals Ltd	Compostos de pirazol e a sua utilização como bloqueadores de canais de cálcio do tipo t
BE1023340B1 (fr)	2014-11-13	2017-02-08	Glaxosmithkline Biologicals S.A.	Composes
WO2017093180A1 (de)	2015-12-01	2017-06-08	Bayer Cropscience Aktiengesellschaft	Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
JP6411676B2 (ja)	2015-12-03	2018-10-24	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＤｅｖｅｌｏｐｍｅｎｔＬｉｍｉｔｅｄ	Ｓｔｉｎｇの調節因子としての環状プリンジヌクレオチド
CR20200045A (es)	2016-04-07	2020-03-11	Glaxosmithkline Ip Dev Ltd	AMIDAS HETEROCÍCLICAS ÚTILES COMO MODULADORES DE PROTEÍNAS (Divisional 2018-0472)
SG11201808708RA (en)	2016-04-07	2018-11-29	Glaxosmithkline Ip Dev Ltd	Heterocyclic amides useful as protein modulators
WO2018033455A1 (de)	2016-08-15	2018-02-22	Bayer Cropscience Aktiengesellschaft	Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
EP3301094A1 (en) *	2016-09-30	2018-04-04	Mutabilis	Heterocyclic compounds and their use in preventing or treating bacterial infections
MA49114A (fr)	2016-12-16	2020-03-25	Idorsia Pharmaceuticals Ltd	Combinaison pharmaceutique comprenant un bloqueur de canal calcique de type t
US10899695B2 (en)	2017-02-06	2021-01-26	Idorsia Pharmaceuticals Ltd	Process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes
MX2020003604A (es)	2017-10-04	2020-07-28	Bayer Ag	Derivados heterociclicos como pesticidas.
JP7291130B2 (ja)	2017-10-05	2023-06-14	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド	インターフェロン遺伝子の刺激物質（ｓｔｉｎｇ）の調節物質
JP2020536106A (ja)	2017-10-05	2020-12-10	グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＤｅｖｅｌｏｐｍｅｎｔＬｉｍｉｔｅｄ	Ｈｉｖの処置に有用なインターフェロン遺伝子の刺激物質（ｓｔｉｎｇ）の調節物質
EP3765466B1 (de)	2018-03-12	2022-05-25	Bayer Aktiengesellschaft	Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
US20210169080A1 (en)	2018-04-20	2021-06-10	Bayer Aktiengesellschaft	Heterocycle derivatives as pesticides
GB201807924D0 (en)	2018-05-16	2018-06-27	Ctxt Pty Ltd	Compounds
EP3969438A1 (en)	2019-05-16	2022-03-23	Stingthera, Inc.	Oxoacridinyl acetic acid derivatives and methods of use
US20220251079A1 (en)	2019-05-16	2022-08-11	Stingthera, Inc.	Benzo[b][1,8]naphthyridine acetic acid derivatives and methods of use
GB201910304D0 (en)	2019-07-18	2019-09-04	Ctxt Pty Ltd	Compounds
GB201910305D0 (en)	2019-07-18	2019-09-04	Ctxt Pty Ltd	Compounds
CN112194620B (zh) *	2020-12-04	2021-02-26	苏州开元民生科技股份有限公司	一种2-乙基-4-氰基吡啶的制备方法
CN113563167B (zh) *	2021-07-16	2023-09-08	南通华祥医药科技有限公司	一种2-甲基-1-四氢萘酮的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3786063A (en)	1971-05-24	1974-01-15	Universal Oil Prod Co	Thiazolethiosulfonates
DE2155360C3 (de) *	1971-11-08	1980-04-03	Cassella Ag, 6000 Frankfurt	Verfahren zur Herstellung von Acylbernsteinsäuredialkylestern
CA1140049A (en)	1977-12-22	1983-01-25	Dke J.E. Helgstran	Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid
US4326058A (en)	1979-02-05	1982-04-20	Sumitomo Chemical Company, Limited	Organo-phosphoric esters and their production and use
US4489077A (en)	1983-03-23	1984-12-18	Warner-Lambert Company	3-Isoxa-zolyl-2H-1,2-benzothiazine-3-carboxamide, 1,1-dioxides
US6174868B1 (en)	1992-09-10	2001-01-16	Isis Pharmaceuticals, Inc.	Compositions and methods for treatment of hepatitis C virus-associated diseases
US5846964A (en)	1993-07-19	1998-12-08	Tokyo Tanabe Company Limited	Hepatitis C virus proliferation inhibitor
US5504104A (en)	1993-11-19	1996-04-02	Warner-Lambert Company	Tricyclic pyrone derivatives as protease inhibitors and antiviral agents
US5808062A (en)	1993-11-19	1998-09-15	Warner-Lambert Company	Pyrone derivatives as protease inhibitors and antiviral agents
US5840751A (en)	1993-11-19	1998-11-24	Warner-Lambert Company	5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
RU2160733C2 (ru)	1993-11-19	2000-12-20	Парк, Дэвис энд Компани	Производные пирона и их фармацевтически приемлемые соли, промежуточные соединения для их получения, фармацевтическая композиция с антивирусной и антибактериальной активностью на их основе, способ лечения вызванных ретровирусом инфекции или заболевания
WO1995014012A1 (en)	1993-11-19	1995-05-26	Parke, Davis & Company	5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
US5834506A (en) *	1996-11-01	1998-11-10	Warner-Lambert Company	Dihydropyrones with improved antiviral activity
AU773567B2 (en)	1998-09-11	2004-05-27	Warner-Lambert Company	HIV protease inhibitors
US6512006B1 (en)	1999-12-09	2003-01-28	Warner-Lambert Company	HIV protease inhibitors
EP1256628A3 (en)	2001-05-10	2003-03-19	Agouron Pharmaceuticals, Inc.	Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
DOP2003000641A (es) *	2002-05-10	2003-11-15	Pfizer	Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en) *	2003-02-21	2006-12-12	Agouron Pharmaceuticals, Inc.	Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
WO2006018725A1 (en) *	2004-08-18	2006-02-23	Pfizer Inc.	Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same

2005
- 2005-08-05 WO PCT/IB2005/002697 patent/WO2006018725A1/en active Application Filing
- 2005-08-05 BR BRPI0514425-6A patent/BRPI0514425A/pt not_active IP Right Cessation
- 2005-08-05 PT PT05775853T patent/PT1781662E/pt unknown
- 2005-08-05 EA EA200700338A patent/EA012605B1/ru not_active IP Right Cessation
- 2005-08-05 CA CA2577525A patent/CA2577525C/en not_active Expired - Fee Related
- 2005-08-05 RS RS20110257A patent/RS51794B/en unknown
- 2005-08-05 DK DK05775853.4T patent/DK1781662T3/da active
- 2005-08-05 JP JP2007526609A patent/JP4372195B2/ja not_active Expired - Fee Related
- 2005-08-05 AU AU2005273619A patent/AU2005273619B2/en not_active Ceased
- 2005-08-05 AP AP2007003918A patent/AP2313A/xx active
- 2005-08-05 GE GEAP200510998A patent/GEP20115305B/en unknown
- 2005-08-05 GE GEAP20059868A patent/GEP20094751B/en unknown
- 2005-08-05 PL PL05775853T patent/PL1781662T3/pl unknown
- 2005-08-05 SI SI200531314T patent/SI1781662T1/sl unknown
- 2005-08-05 CN CN2009101381353A patent/CN101538268B/zh not_active Expired - Fee Related
- 2005-08-05 EP EP05775853A patent/EP1781662B1/en active Active
- 2005-08-05 DE DE602005027580T patent/DE602005027580D1/de active Active
- 2005-08-05 NZ NZ552874A patent/NZ552874A/en not_active IP Right Cessation
- 2005-08-05 MX MX2007001527A patent/MX2007001527A/es active IP Right Grant
- 2005-08-05 CN CN2005800280919A patent/CN101006092B/zh not_active Expired - Fee Related
- 2005-08-05 ES ES05775853T patent/ES2361845T3/es active Active
- 2005-08-05 KR KR1020077006118A patent/KR100851178B1/ko active IP Right Grant
- 2005-08-05 AT AT05775853T patent/ATE506364T1/de active
- 2005-08-05 UA UAA200700852A patent/UA88909C2/ru unknown
- 2005-08-12 MY MYPI20053809A patent/MY146123A/en unknown
- 2005-08-15 PE PE2005000945A patent/PE20060677A1/es not_active Application Discontinuation
- 2005-08-15 UY UY29068A patent/UY29068A1/es not_active Application Discontinuation
- 2005-08-15 US US11/204,269 patent/US7151105B2/en not_active Expired - Fee Related
- 2005-08-16 AR ARP050103438A patent/AR050699A1/es active IP Right Grant
- 2005-08-16 GT GT200500221A patent/GT200500221A/es unknown
- 2005-08-17 NL NL1029755A patent/NL1029755C2/nl not_active IP Right Cessation
- 2005-08-17 TW TW094128016A patent/TWI376379B/zh not_active IP Right Cessation
- 2005-08-18 SV SV2005002202A patent/SV2007002202A/es not_active Application Discontinuation
- 2005-08-18 HN HN2005000449A patent/HN2005000449A/es unknown
2006
- 2006-09-06 US US11/470,540 patent/US7622605B2/en not_active Expired - Fee Related
2007
- 2007-01-24 IL IL180933A patent/IL180933A/en not_active IP Right Cessation
- 2007-01-26 ZA ZA200700779A patent/ZA200700779B/xx unknown
- 2007-02-15 NI NI200700043A patent/NI200700043A/es unknown
- 2007-02-16 MA MA29684A patent/MA28803B1/fr unknown
- 2007-02-16 TN TNP2007000066A patent/TNSN07066A1/fr unknown
- 2007-02-16 EC EC2007007264A patent/ECSP077264A/es unknown
- 2007-02-16 CR CR8935A patent/CR8935A/es unknown
- 2007-03-08 NO NO20071274A patent/NO20071274L/no not_active Application Discontinuation
2008
- 2008-01-07 HK HK08100120.5A patent/HK1109617A1/xx not_active IP Right Cessation
- 2008-07-20 IL IL192919A patent/IL192919A0/en unknown
2009
- 2009-07-15 US US12/503,286 patent/US8268835B2/en not_active Expired - Fee Related
2011
- 2011-03-21 CR CR20110153A patent/CR20110153A/es unknown
- 2011-05-17 CY CY20111100486T patent/CY1111480T1/el unknown
- 2011-06-17 HR HR20110458T patent/HRP20110458T1/hr unknown

Also Published As

Publication number	Publication date
JP4372195B2 (ja)	2009-11-25
CR20110153A (es)	2011-04-26
AP2007003918A0 (en)	2007-02-28
CA2577525A1 (en)	2006-02-23
CN101538268A (zh)	2009-09-23
HN2005000449A (es)	2009-10-30
JP2008509984A (ja)	2008-04-03
KR100851178B1 (ko)	2008-08-08
EA012605B1 (ru)	2009-10-30
HRP20110458T1 (hr)	2011-07-31
NZ552874A (en)	2010-04-30
EP1781662A1 (en)	2007-05-09
CA2577525C (en)	2010-03-30
US7622605B2 (en)	2009-11-24
PT1781662E (pt)	2011-07-01
DK1781662T3 (da)	2011-06-27
DE602005027580D1 (de)	2011-06-01
EP1781662B1 (en)	2011-04-20
MA28803B1 (fr)	2007-08-01
GEP20115305B (en)	2011-10-10
SV2007002202A (es)	2007-03-20
CY1111480T1 (el)	2015-08-05
KR20070044057A (ko)	2007-04-26
TNSN07066A1 (fr)	2008-06-02
US20070015764A1 (en)	2007-01-18
US8268835B2 (en)	2012-09-18
CR8935A (es)	2007-07-24
AP2313A (en)	2011-10-31
US7151105B2 (en)	2006-12-19
RS51794B (en)	2011-12-31
US20090281122A1 (en)	2009-11-12
ES2361845T3 (es)	2011-06-22
IL192919A0 (en)	2009-02-11
MX2007001527A (es)	2007-03-27
NL1029755A1 (nl)	2006-02-21
NO20071274L (no)	2007-05-14
WO2006018725A1 (en)	2006-02-23
TWI376379B (en)	2012-11-11
ATE506364T1 (de)	2011-05-15
BRPI0514425A (pt)	2008-06-10
ECSP077264A (es)	2007-04-26
AU2005273619A1 (en)	2006-02-23
GEP20094751B (en)	2009-08-10
PE20060677A1 (es)	2006-08-11
PL1781662T3 (pl)	2011-08-31
CN101538268B (zh)	2011-07-27
US20060122399A1 (en)	2006-06-08
NI200700043A (es)	2008-01-02
UY29068A1 (es)	2006-03-31
IL180933A (en)	2011-08-31
HK1109617A1 (en)	2008-06-13
MY146123A (en)	2012-06-29
UA88909C2 (ru)	2009-12-10
EA200700338A1 (ru)	2007-08-31
TW200612898A (en)	2006-05-01
AR050699A1 (es)	2006-11-15
NL1029755C2 (nl)	2006-10-18
IL180933A0 (en)	2007-07-04
CN101006092B (zh)	2013-04-17
AU2005273619B2 (en)	2009-05-28
CN101006092A (zh)	2007-07-25
GT200500221A (es)	2006-06-21
ZA200700779B (en)	2008-11-26

Publication	Publication Date	Title
IL180933A0 (en)	2007-07-04	Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
AU2003224371A1 (en)	2003-11-11	Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
WO2007140200A3 (en)	2008-02-14	Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
WO2007140254A3 (en)	2008-01-24	Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
WO2007092888A3 (en)	2007-10-11	Hcv ns5b inhibitors
NL1025544A1 (nl)	2004-08-24	Remmers van rna-afhankelijk rna-polymerase van hepatitis-c-virus en preparaten en behandelingen waarbij ze worden gebruikt.
WO2004073599A3 (en)	2004-12-23	Inhibitors of hepatitis c virus, compositions and treatments using the same
EP1556399A4 (en)	2007-09-26	NUCLEOSIDE DERIVATIVES AS RNA-DEPENDENT VIRAL RNA POLYMERASE INHIBITORS
IL198248A0 (en)	2009-12-24	Hepatitis c virus inhibitors and compositions comprising the same
AU2003256619A8 (en)	2004-02-09	Thionucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
EP1742958A4 (en)	2009-08-05	METHODS AND COMPOSITIONS FOR SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE STRANDED RNA
HUP0402065A3 (en)	2013-06-28	Hepatitis c virus polymerase inhibitors with heterobicyclic structure, process for their preparation and pharmaceutical compositions containing them
EP1915054A4 (en)	2010-09-01	CYCLIC ACETAL DERIVATIVES OF RIBONUCLEOSIDES FOR THE TREATMENT OF RNA-DEPENDENT RNA VIRUS INFECTIONS
HUP0400726A3 (en)	2007-05-29	Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
EP1684787A4 (en)	2009-08-05	INHIBITORS OF HEPATITIS C VIRUS
EP1684745A4 (en)	2008-11-19	INHIBITORS OF HEPATITIS C VIRUS
TW200745035A (en)	2007-12-16	Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
WO2007092645A3 (en)	2007-10-04	Novel hcv inhibitor combinations and methods
IL188320A (en)	2014-07-31	Macrocyclic inhibitors of the hepatitis c virus, pharmaceutical preparations that include them and their production
IL182583A0 (en)	2007-07-24	4-methoxymethyl-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors
SI2209789T1 (sl)	2012-06-29	Ciklopropil zliti indolobenzazepin hcv ns5b inhibitorji
WO2009029384A3 (en)	2009-05-28	Compounds for the treatment of hepatitis c
WO2005034850A3 (en)	2006-03-16	Cycloalkyl heterocycles for treating hepatitis c virus
ZA200701674B (en)	2008-08-27	Vaccine composition against Hepatitis C virus
HK1134676A1 (en)	2010-05-07	Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same c